Clinical Trial Update: Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites. [Phase 4]

View source ↗

Summary

Phase 4 trial update on long-term administration of Albumin 20% in patients with cirrhosis and ascites.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Drugs mentioned

• Albumin 20% (human albumin solution 20%)

Snippet

Sponsor: Instituto Grifols, S.A. | Conditions: Cirrhosis, Ascites | Phase 4 | Status: COMPLETED